Filing Details
- Accession Number:
- 0001104659-21-078924
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-09 17:48:37
- Reporting Period:
- 2021-06-07
- Accepted Time:
- 2021-06-09 17:48:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124524 | Cryoport Inc. | CYRX | Pharmaceutical Preparations (2834) | 880313393 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1764017 | M Daniel Hancock | C/O Cryoport Inc. 112 Westwood Place, Suite 350 Brentwood TN 37027 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-07 | 10,000 | $9.73 | 14,627 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-07 | 10,000 | $60.02 | 4,627 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-06-08 | 10,000 | $9.73 | 14,627 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-08 | 10,000 | $61.23 | 4,627 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to purchase common stock | Disposition | 2021-06-07 | 10,000 | $0.00 | 10,000 | $9.73 |
| Common Stock | Option to purchase common stock | Disposition | 2021-06-08 | 10,000 | $0.00 | 10,000 | $9.73 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,000 | 2029-01-04 | No | 4 | M | Direct | |
| 30,000 | 2029-01-04 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.90 to $60.31, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- 1/36 of the options originally granted vested on the 4th day of each month for the twelve months beginning on February 4, 2019.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.84, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
